Immunotherapy for relapse following haploidentical HSCT: Donor lymphocyte infusion (DLI), checkpoint inhibitor (CPI) antibody, or both?

November 5, 2021 - 8:30am to 9:30am
Series
Hematologic Malignancies Grand Rounds
Speaker
Dr. Richard Lopez

Hematologic Malignancies Grand Rounds is a weekly teaching conference for hematologic malignancies providers to be able to utilize multidisciplinary methods to keep up with the most current treatment guidelines and changing standards of care for their patients.